Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.96
+0.01000.13%
Volume:22.27K
Turnover:177.76K
Market Cap:54.09M
PE:-0.70
High:8.15
Open:7.94
Low:7.80
Close:7.95
Loading ...
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report